These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11436115)

  • 1. Mucositis associated with stem cell transplantation: current status and innovative approaches to management.
    Stiff P
    Bone Marrow Transplant; 2001 May; 27 Suppl 2():S3-S11. PubMed ID: 11436115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation.
    Freytes CO; Ratanatharathorn V; Taylor C; Abboud C; Chesser N; Restrepo A; Arango J; Odenheimer D
    Clin Cancer Res; 2004 Dec; 10(24):8318-24. PubMed ID: 15623608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mucositis--a major non-hematologic complication of high-dose chemotherapy and radiotherapy--pathogenesis, prevention and treatment].
    Piatkowska-Jakubas B; Darczuk D; Chomyszyn-Gajewska M; Skotnicki AB
    Przegl Lek; 2003; 60(12):815-20. PubMed ID: 15058023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens.
    Cutler C; Li S; Kim HT; Laglenne P; Szeto KC; Hoffmeister L; Harrison MJ; Ho V; Alyea E; Lee SJ; Soiffer R; Sonis S; Antin JH
    Biol Blood Marrow Transplant; 2005 May; 11(5):383-8. PubMed ID: 15846292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palifermin (Kepivance) for the treatment of oral mucositis in patients with hematologic malignancies requiring hematopoietic stem cell support.
    Radtke ML; Kolesar JM
    J Oncol Pharm Pract; 2005 Sep; 11(3):121-5. PubMed ID: 16390600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multivariable analysis of factors influencing mucositis after autologous progenitor cell transplantation.
    Bolwell BJ; Kalaycio M; Sobecks R; Andresen S; Kuczkowski E; Bernhard L; Lomax R; Kohuth J; Mendiola S; Rybicki L; Pohlman B
    Bone Marrow Transplant; 2002 Nov; 30(9):587-91. PubMed ID: 12407433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivariate analysis of factors influencing oral mucositis in allogeneic hematopoietic stem cell transplantation.
    Ohbayashi Y; Imataki O; Ohnishi H; Iwasaki A; Ogawa T; Inagaki N; Shigeta H; Ohue Y; Tasaka T; Kitanaka A; Kubota Y; Tanaka T; Ishida T; Miyake M
    Ann Hematol; 2008 Oct; 87(10):837-45. PubMed ID: 18553082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral mucositis.
    Scully C; Sonis S; Diz PD
    Oral Dis; 2006 May; 12(3):229-41. PubMed ID: 16700732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of anti-infective mouth rinses and concomitant antibiotic prophylaxis to decrease oral mucosal colonization in autologous stem cell transplantation.
    Lövenich H; Schütt-Gerowitt H; Keulertz C; Waldschmidt D; Bethe U; Söhngen D; Cornely OA
    Bone Marrow Transplant; 2005 May; 35(10):997-1001. PubMed ID: 15806134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing the toxicity of hematopoietic stem cell transplant.
    Pallera AM; Schwartzberg LS
    J Support Oncol; 2004; 2(3):223-37; discussion 237-8, 241, 246-7. PubMed ID: 15328824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.
    Fassas A; Passweg JR; Anagnostopoulos A; Kazis A; Kozak T; Havrdova E; Carreras E; Graus F; Kashyap A; Openshaw H; Schipperus M; Deconinck E; Mancardi G; Marmont A; Hansz J; Rabusin M; Zuazu Nagore FJ; Besalduch J; Dentamaro T; Fouillard L; Hertenstein B; La Nasa G; Musso M; Papineschi F; Rowe JM; Saccardi R; Steck A; Kappos L; Gratwohl A; Tyndall A; Samijn J;
    J Neurol; 2002 Aug; 249(8):1088-97. PubMed ID: 12195460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase Ib clinical trial of PV701, a milk-derived protein extract, for the prevention and treatment of oral mucositis in patients undergoing high-dose BEAM chemotherapy.
    Prince HM; Regester G; Gates P; Jablonskis L; Seymour JF; Lillie K; West R; Wolf M; Januszewicz H; Belford D
    Biol Blood Marrow Transplant; 2005 Jul; 11(7):512-20. PubMed ID: 15983551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia.
    Robien K; Schubert MM; Bruemmer B; Lloid ME; Potter JD; Ulrich CM
    J Clin Oncol; 2004 Apr; 22(7):1268-75. PubMed ID: 15051775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind randomized placebo-controlled study of oral glutamine in the prevention of mucositis in children undergoing hematopoietic stem cell transplantation: a pediatric blood and marrow transplant consortium study.
    Aquino VM; Harvey AR; Garvin JH; Godder KT; Nieder ML; Adams RH; Jackson GB; Sandler ES
    Bone Marrow Transplant; 2005 Oct; 36(7):611-6. PubMed ID: 16086046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation.
    Bacigalupo A; Sormani MP; Lamparelli T; Gualandi F; Occhini D; Bregante S; Raiola AM; di Grazia C; Dominietto A; Tedone E; Piaggio G; Podesta M; Bruno B; Oneto R; Lombardi A; Frassoni F; Rolla D; Rollandi G; Viscoli C; Ferro C; Garbarino L; Van Lint MT
    Haematologica; 2004 Oct; 89(10):1238-47. PubMed ID: 15477210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention and treatment of chemo- and radiotherapy-induced oral mucositis.
    Demarosi F; Bez C; Carrassi A
    Minerva Stomatol; 2002 May; 51(5):173-86. PubMed ID: 12070468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of biomedical and psychosocial factors for the prediction of pain and distress in patients undergoing high-dose therapy and BMT/PBSCT.
    Schulz-Kindermann F; Hennings U; Ramm G; Zander AR; Hasenbring M
    Bone Marrow Transplant; 2002 Feb; 29(4):341-51. PubMed ID: 11896432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal protection by cytokines.
    Hofmeister CC; Stiff PJ
    Curr Hematol Rep; 2005 Nov; 4(6):446-53. PubMed ID: 16232381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infections during mobilizing chemotherapy and following autologous stem cell transplantation.
    Toor AA; van Burik JA; Weisdorf DJ
    Bone Marrow Transplant; 2001 Dec; 28(12):1129-34. PubMed ID: 11803354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.